I did 6 hours of research on Cytodyn yesterday .Mo

I did 6 hours of research on Cytodyn yesterday .Mostly on the science . If management handles this correctly and BP doesn’t crush it , this could become the next Amgen . The slowness of management is actually very good for the company longtime . The biggest help in understanding the company was listening to the hour investor call early March . Licensing deals become the next step . One because they need money . Glad they didn’t rush to do it and give away the farm . With so many indications , the negotiations will be intricate. I’m starting to believe the financing was small , because they know they have something very big and truly don’t want to Willy Nilly dilute the crap out of this . Upfront licensing hopefully will include big upfront payments and large royalty percentages , because of so many groundbreaking indications . We need smart decision making by the team . Which exec has that quality of huge deal making ? I think they could sell company easily , but what are they willing to accept . Do they hang on get quick abit of funds and go it alone or not . THIS IS BIG . AND MAYBE THE HOLY GRAIL OF CANCER . I have been investing 40 years , so my words have a little experience and knowledge . It’s the understanding of what they have that is mind boggling .. Watching with intense interest . Hoping things transpire fruitfully